Gilead Sciencs

Gilead Sciences to pay $300 million for nearly half of Tizona, has option to buy the rest for $1.25 billion
Marketwatch
Tue, 07/21/20 - 10:28 am
Gilead Sciencs
Tizona Therapeutics
M&A
cancer
[video]Here’s Why Gilead Sciences' Jump Into Gene Editing Is Important
Motley Fool
Sat, 03/3/18 - 11:12 am
Gilead Sciencs
gene editing
Sangamo Therapeutics
cancer